Cas no 885275-55-8 (5-Chloro-2-methyl-imidazo1,2-apyridine-3-carboxylic Acid)
5-Chloro-2-methyl-imidazo1,2-apyridine-3-carboxylic Acid Chemical and Physical Properties
Names and Identifiers
-
- 5-Chloro-2-methylimidazo[1,2-a]pyridine-3-carboxylic acid
- 5-Chloro-2-methyl-imidazo[1,2-a]pyridine-3-carboxylic acid
- 5-Chloro-2-methylimidazo-[1,2-a]pyridine-3-carboxylic acid
- Imidazo[1,2-a]pyridine-3-carboxylicacid, 5-chloro-2-methyl-
- AKOS022175698
- SCHEMBL7825354
- DTXSID10370928
- AB07195
- FT-0647312
- MFCD00798110
- TS-02996
- 885275-55-8
- DB-077648
- 5-Chloro-2-methylimidazo[1,2-a]pyridine-3-carboxylicacid
- 5-Chloro-2-methyl-imidazo1,2-apyridine-3-carboxylic Acid
-
- MDL: MFCD00798110
- Inchi: 1S/C9H7ClN2O2/c1-5-8(9(13)14)12-6(10)3-2-4-7(12)11-5/h2-4H,1H3,(H,13,14)
- InChI Key: KGGHLBBFRZSXPG-UHFFFAOYSA-N
- SMILES: ClC1=CC=CC2=NC(C)=C(C(=O)O)N21
Computed Properties
- Exact Mass: 210.02000
- Monoisotopic Mass: 210.0196052g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 1
- Hydrogen Bond Acceptor Count: 4
- Heavy Atom Count: 14
- Rotatable Bond Count: 1
- Complexity: 249
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- Surface Charge: 0
- Tautomer Count: nothing
- XLogP3: 3
- Topological Polar Surface Area: 54.6?2
Experimental Properties
- PSA: 54.60000
- LogP: 1.99430
5-Chloro-2-methyl-imidazo1,2-apyridine-3-carboxylic Acid Security Information
- Hazard Statement: Irritant
-
Hazardous Material Identification:
5-Chloro-2-methyl-imidazo1,2-apyridine-3-carboxylic Acid Customs Data
- HS CODE:2933990090
- Customs Data:
China Customs Code:
2933990090Overview:
2933990090. Other heterocyclic compounds containing only nitrogen heteroatoms. VAT:17.0%. Tax refund rate:13.0%. Regulatory conditions:nothing. MFN tariff:6.5%. general tariff:20.0%
Declaration elements:
Product Name, component content, use to, Please indicate the appearance of Urotropine, 6- caprolactam please indicate the appearance, Signing date
Summary:
2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%
5-Chloro-2-methyl-imidazo1,2-apyridine-3-carboxylic Acid Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| JIE DA WEI ( SHANG HAI ) YI YAO KE JI FA ZHAN Co., Ltd. | 68R0145-1g |
5-Chloro-2-methyl-imidazo[1,2-a]pyridine-3-carboxylic acid |
885275-55-8 | 96% | 1g |
5071.29CNY | 2021-05-07 | |
| JIE DA WEI ( SHANG HAI ) YI YAO KE JI FA ZHAN Co., Ltd. | 68R0145-5g |
5-Chloro-2-methyl-imidazo[1,2-a]pyridine-3-carboxylic acid |
885275-55-8 | 96% | 5g |
16943.89CNY | 2021-05-07 | |
| JIE DA WEI ( SHANG HAI ) YI YAO KE JI FA ZHAN Co., Ltd. | 68R0145-500mg |
5-Chloro-2-methyl-imidazo[1,2-a]pyridine-3-carboxylic acid |
885275-55-8 | 96% | 500mg |
2959.67CNY | 2021-05-07 | |
| JIE DA WEI ( SHANG HAI ) YI YAO KE JI FA ZHAN Co., Ltd. | 68R0145-250mg |
5-Chloro-2-methyl-imidazo[1,2-a]pyridine-3-carboxylic acid |
885275-55-8 | 96% | 250mg |
1908.1CNY | 2021-05-07 | |
| JIE DA WEI ( SHANG HAI ) YI YAO KE JI FA ZHAN Co., Ltd. | 68R0145-100mg |
5-Chloro-2-methyl-imidazo[1,2-a]pyridine-3-carboxylic acid |
885275-55-8 | 96% | 100mg |
1382.31CNY | 2021-05-07 | |
| JIE DA WEI ( SHANG HAI ) YI YAO KE JI FA ZHAN Co., Ltd. | 68R0145-50mg |
5-Chloro-2-methyl-imidazo[1,2-a]pyridine-3-carboxylic acid |
885275-55-8 | 96% | 50mg |
1102.46CNY | 2021-05-07 | |
| abcr | AB537720-100 mg |
5-Chloro-2-methyl-imidazo[1,2-a]pyridine-3-carboxylic acid; . |
885275-55-8 | 100MG |
€542.50 | 2023-07-11 | ||
| Chemenu | CM271049-100mg |
5-Chloro-2-methylimidazo[1,2-a]pyridine-3-carboxylic acid |
885275-55-8 | 95+% | 100mg |
$246 | 2021-08-18 | |
| Chemenu | CM271049-250mg |
5-Chloro-2-methylimidazo[1,2-a]pyridine-3-carboxylic acid |
885275-55-8 | 95+% | 250mg |
$352 | 2021-08-18 | |
| Chemenu | CM271049-1g |
5-Chloro-2-methylimidazo[1,2-a]pyridine-3-carboxylic acid |
885275-55-8 | 95+% | 1g |
$821 | 2021-08-18 |
5-Chloro-2-methyl-imidazo1,2-apyridine-3-carboxylic Acid Related Literature
-
Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119
-
J. Xu,T. J. Carrocci,A. A. Hoskins Chem. Commun., 2016,52, 549-552
-
Marcin Czapla,Jack Simons Phys. Chem. Chem. Phys., 2018,20, 21739-21745
-
Fereshteh Bayat Environ. Sci.: Nano, 2021,8, 367-389
-
Vishwesh Venkatraman,Marco Foscato,Vidar R. Jensen,Bj?rn K?re Alsberg J. Mater. Chem. A, 2015,3, 9851-9860
Additional information on 5-Chloro-2-methyl-imidazo1,2-apyridine-3-carboxylic Acid
Market Research and Analysis of 5-Chloro-2-methyl-imidazo1,2-apyridine-3-carboxylic Acid (CAS No. 885275-55-8)
The compound 5-Chloro-2-methyl-imidazo1,2-apyridine-3-carboxylic Acid, identified by the CAS number 885275-55-8, has garnered significant attention in the chemical and pharmaceutical industries due to its unique properties and potential applications in drug development. This research brief provides an in-depth analysis of the current market landscape, recent advancements, and future prospects for this compound.
Recent studies have highlighted the compound's potential as a lead molecule in the development of novel therapeutic agents. Its structural features, including the imidazoapyridine scaffold and chlorine substituent, contribute to its pharmacokinetic properties and biological activity. Researchers have explored its role in various therapeutic areas, such as oncology, inflammation, and infectious diseases.
The global market for specialty chemicals like 5-Chloro-2-methyl-imidazo1,2-apyridine-3-carboxylic Acid is driven by increasing demand from pharmaceutical companies engaged in drug discovery and development. Key regions such as North America, Europe, and Asia-Pacific are witnessing significant growth due to robust R&D investments and expanding healthcare sectors.
From a supply chain perspective, several chemical manufacturers specialize in the synthesis and supply of this compound. These suppliers cater to both academic institutions and industry players, ensuring a steady flow of high-quality materials for research and commercial purposes. The competitive landscape is characterized by technological advancements and strategic partnerships aimed at optimizing production processes and reducing costs.
In terms of market demand, the compound's demand is primarily driven by its use in preclinical studies and early-stage clinical trials. Pharmaceutical companies are increasingly focusing on leveraging such compounds to accelerate their pipeline development. Additionally, regulatory reforms promoting innovation in drug development further stimulate the demand for high-purity chemical intermediates like this one.
To conclude, 5-Chloro-2-methyl-imidazo1,2-apyridine-3-carboxylic Acid (CAS No. 885275-55-8) holds promising potential in the field of chemical biology and drug discovery. As research progresses and its therapeutic applications become more defined, the market for this compound is expected to grow steadily. Stakeholders in the industry should remain vigilant to emerging trends and technological advancements to capitalize on these opportunities effectively.
885275-55-8 (5-Chloro-2-methyl-imidazo1,2-apyridine-3-carboxylic Acid) Related Products
- 198895-50-0(Imidazo[1,2-a]pyridine-3-carboxaldehyde, 5-chloro-)
- 138642-96-3(6-Chloro-2-methylimidazo1,2-apyridine-3-carboxylic acid)
- 1268520-94-0(5-chloro-3-methylimidazo[1,2-a]pyridine-2-carboxylic acid)
- 1352396-23-6(ethyl 5-chloro-3-methylimidazo[1,2-a]pyridine-2-carboxylate)
- 1000017-93-5(5-Chloroimidazo1,2-apyridine-2-carboxylic Acid)
- 1159833-58-5(7-Chloro-3-methylimidazo[1,2-a]-pyridine-2-carboxylic acid)
- 21801-79-6(2-Methylimidazo[1,2-a]pyridine-3-carboxylic acid)
- 1159829-22-7(7-Chloro-2-methylimidazo-[1,2-a]pyridine-3-carboxylic acid)
- 1159831-22-7(6-chloro-3-methylimidazo[1,2-a]pyridine-2-carboxylic acid)
- 885271-51-2(5-Chloro-imidazo1,2-apyridine-3-carboxylic Acid ethyl ester)